SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Political Economy Of FDA Drug Review: Processing, Politics, And Lessons For Policy
4 references·4 citing·40 second hop
The Political Economy Of FDA Drug Review: Processing, Politics, And Lessons For Policy (2004)The Political Economy Of FDA Drug Review:…Protection without Capture: Product Approval by a Politically Responsive, Learning Regulator (2004)Protection without Capture: P…Groups, the Media, Agency Waiting Costs, and FDA Drug Approval (2002)Groups, the Media, Agency Wai…Adaptive Signal Processing, Hierarchy, and Budgetary Control in Federal Regulation (1996)Adaptive Signal Processing, H…Agendas and instability in American politics (1993)Agendas and instability in Am…Pushing for speed or scope? Pharmaceutical lobbying and Food and Drug Administration drug review (2019)Pushing for speed or scope? P…Federal Advisory Committees, Policy Expertise, and the Approval of Drugs and Medical Devices at the FDA (2010)Federal Advisory Committees, …Pharmaceutical Governance (2006)Pharmaceutical GovernanceEvidence, Politics, And Technological Change (2005)Evidence, Politics, And Techn…Professional uncertainty and the problem of supplier-induced demand (1982)The Dynamics of Technological Change in Medicine (1994)Economic foundations of cost-effectiveness analysis (1997)The application of special technologies in diagnostic anatomic pathology: is it consistent with the principles of evidence-based medicine? (2005)Ciência, tecnologia e inovação em saúde e desenvolvimento social e qualidade de vida: teses para debate (2007)Administrative Procedures as Instruments of Political Control (1987)Structure and Process, Politics and Policy: Administrative Arrangements and the Political Control of Agencies (1989)The fifth branch: science advisers as policymakers (1991)The role Of citizen advisory boards during times Of fiscal stress (2016)Constructed collaboration: facilitating innovative exchange when networks are thin or divided (2025)The Logic of Collective Action. (1966)Job Matching and the Theory of Turnover (1979)Sweet-Talking the Fourth Branch: The Influence of Interest Group Comments on Federal Agency Rulemaking (2005)Brownian Motion and Stochastic Calculus (2007)Pharmaceutical Price Controls and Entry Strategies (2007)Information Exchange in Policy Networks (2012)Toward a More General Theory of Regulation (1976)Shaping Democratic Practice and the Causes of Electoral Fraud: The Case of Nineteenth-Century Germany (2009)Lords of the Harvest: Third-Party Influence and Regulatory Approval of Genetically Modified Organisms (2012)Demand, challenges, and innovation. Making sense of new trends in innovation policy (2018)Theory of the Consumption Function (1957)A Theory of the Consumption Function (1960)Rational Expectations and the Theory of Price Movements (1961)Bounded Rationality and Political Science: Lessons from Public Administration and Public Policy (2003)Information Processing and Policy Dynamics (2009)Organizational Reputation, Regulatory Talk, and Strategic Silence (2012)Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy (1986)First-mover advantages (1988)Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)“High” innovators? Marijuana legalization and regional innovation (2022)Countervailing Claims: Pro-Diversity Responses to Stigma by Association Following the Unite the Right Rally (2023)The consequences of modernity (1990)The Foucault Effect: Studies in Governmentality (1991)Modernity at Large: Cultural Dimensions of Globalization. (1998)Public Health, Patronage and National Culture (2008)Anthropology and the Study of Disability Worlds (2012)Ruins, Redemption, and Brazil's Imperial Exception (2013)The advocacy coalition framework: revisions and relevance for Europe (1998)What to do when Stakeholders matter (2004)The Mechanisms of Policy Diffusion (2008)
this work references cited by second hop

References

  • 1993Agendas and instability in American politics5,981 cited
  • 2002Groups, the Media, Agency Waiting Costs, and FDA Drug Approval335 cited
  • 2004Protection without Capture: Product Approval by a Politically Responsive, Learning Regulator216 cited
  • 1996Adaptive Signal Processing, Hierarchy, and Budgetary Control in Federal Regulation192 cited

Cited by

  • 2006Pharmaceutical Governance87 cited
  • 2005Evidence, Politics, And Technological Change52 cited
  • 2010Federal Advisory Committees, Policy Expertise, and the Approval of Drugs and Medical Devices at the FDA47 cited
  • 2019Pushing for speed or scope? Pharmaceutical lobbying and Food and Drug Administration drug review41 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work